The effect of gabapentin plus celecoxib on pain and associated complications after laminectomy

Journal of Clinical and Diagnostic Research

Volumn 10, Issue 3, 2016, Pages UC04-UC08

  Vasigh, Aminolah ^a   Jaafarpour, Molouk ^a   Khajavikhan, Javaher ^a   Khani, Ali ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Analgesia; Celecoxib; Gabapentin; Lumbar spine surgery; Multimodal therapy

Indexed keywords

ATRACURIUM BESILATE; ATROPINE; CELECOXIB; FENTANYL; GABAPENTIN; ISOFLURANE; MORPHINE; NEOSTIGMINE; PLACEBO; THIOPENTAL;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL (TOPIC); CRONBACH ALPHA COEFFICIENT; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEADACHE; HUMAN; LAMINECTOMY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA AND VOMITING; NON INVASIVE BLOOD PRESSURE MONITOR; PAIN SEVERITY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRURITUS; PULSE OXIMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHIVERING; URINE RETENTION; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84960130939     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2016/17923.7346     Document Type: Article

References (41)

1. Ozgencil E, Yalcin S, Tuna H, Yorukoglu D, Kecik Y. Perioperative administration of gabapentin 1,200 mg day and pregabalin 300 mg day for pain following lumbar laminectomy and discectomy: a randomised, double-blinded, placebocontrolled study. Singapore Med J. 2011;52(12):883-89.
2. Apfelbaun JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anaesth Analg. 2003;97(2):534–40.
3. Melemenl A, Staikou C, Fassoulaki A. Gabapentin for acute and chronic post- surgical pain. SIGNA VITAE. 2007;2(1):42-51.
4. Orak Y, Gunes Y, Bicer S, Ozcengiz D. The Effect of Gabapentin on Postoperative Pain and Opioid-Related Side Effects in Patients Undergoing Combined Spinal-Epidural Anaesthesia (a Preliminary Study). Clinical and Experimental Medical Sciences. 2013;1(6):251-61.
5. Warner DO. Preventing postoperative pulmonary complications. The role of the anaesthesiologist. Anaesthesiology. 2000;92(5):1467–72.
6. Carli F, Zavorsky GS. Optimizing functional exercise capacity in the elderly surgical population. Curr Opin Clin Nutr Metab Care. 2005;8(1):23–32.
7. Mathiesen O, Moiniche S, Dahl JB. Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedure. BMC Anaesthesiology. 2007;7(6):2-15.
8. Kumar KP, Kulkarni DK, Gurajala I, Gopinath R. Pregabalin versus tramadol for postoperative pain management in patients undergoing lumbar laminectomy: a randomized, double-blinded, placebo-controlled study. Journal of Pain Research. 2013;6:471–78.
9. Rahimzadeh P, Sharma V, Imani F, Faiz HR, Ghodraty MR, Nikzad-Jamnani AR, Nader ND. Adjuvant Hyaluronidase to Epidural Steroid Improves the Quality of Analgesia in Failed Back Surgery Syndrome: A Prospective Randomized Clinical Trial. Pain Physician. 2014;17:75-82.
10. Kim SB, Lee KW, Lee JH, Ah Kim M, Woo An B. The Effect of Hyaluronidase in Interlaminar Lumbar Epidural Injection for Failed Back Surgery Syndrome. Ann Rehabil Med. 2012;36:466-73.
11. Porchet F, Vader JP, Larequi-Lauber T, Costanza MC, Burnand B, Dubois RW. The assessment of appropriate indications for laminectomy. J Bone Joint Surg aaaBraaa. 1999;81-B:234-39.
12. Gianesello L, Pavoni V, Barboni E, Galeotti I, Nella A. Perioperative Pregabalin for Postoperative Pain Control and Quality of Life After Major Spinal Surgery. J Neurosurg Anaesthesiol. 2011;0(0):1-6.
13. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618-25.
14. White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anaesth Analg. 2002;94:577-85.
15. Dolin SJ, Cashman JN. Tolerability of acute postoperative pain management: nausea, vomiting, sedation, pruritis and urinary retention. Evidence from puplished data. Br J Anaesth. 2005;95:584-91.
16. White PF. Multimodal analgesia: its role in preventing postoperative pain. Curr Opin Investig Drugs. 2008;9:76–82.
17. White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anaesth Analg. 2005;101:5–22.
18. Reuben SS, Buvanendran A, Kroin JS, Raghunathan K. The Analgesic Efficacy of Celecoxib, Pregabalin, and Their Combination for Spinal Fusion Surgery. Anaesth Analg. 2006;103(5):1271–77.
19. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002;183:630–41.
20. Dahl JB, Mathiesen O, M iniche S. “Protective premedication”: An option with gabapentin and related drugs? A review of gabapentin and pregabalin in the treatment of postoperative pain. Acta Anaesthesiol Scand. 2004;48:1130-36.
21. Seib RK, Paul JE. Preoperative gabapentin for postoperative analgesia: a meta-analysis. Can J Anaesth. 2006;53:461-69.
22. Hurley RW, Cohen SP, Williams KA, Rowlingson AJ, Wu CL. The analgesic effects of perioperative gabapentin on postoperative pain: a meta-analysis. Reg Anaesth Pain Med. 2006;31:237-47.
23. Ho K-Y, Gan TJH, Habib AS. Gabapentin and postoperative pain – a systematic review of randomised controlled trials. Pain. 2006;126:91-101.
24. Syal K, Goma M, Dogra RK, Ohri A, Gupta AK, Goel A. Protective Premedication”: A Comparative Study of Acetaminophen, Gabapentin and Combination of Acetaminophen with Gabapentin for Postoperative Analgesia. J Anaesth Clin Pharmacol. 2010;26(4):531-36.
25. Liporaci Juniot JL. Assesment of preemptive analgesia efficacy in surgical extraction of third molars. Rev Baras Anaesthesiol. 2012;62(4):502-10.
26. Rahimi M, Naser Zareh M, Siavashi B, Amiri SR. The Effectiveness of Different Doses of Gabapentin in Controlling Postoperative Pain. Journal of Iran Surgery. 2014;22(1):44-49.
27. Pandey CK, Priye S, Ambesh SP, Singh S, Singh U, Singh PK. Prophylactic Gabapentin for prevention of postopretive nausea and vomiting in patients undergoing laparoscopic cholesystectomy . A randomized double blind, placebo controlled study. J Postgrad Med. 2006;52(2):97-100.
28. Bafna U, Rajarajeshwaran K, Khandelwal M, Prakash Verma A. A comparison of effect of preemptive use of oral gabapentin and pregabalin for acute postoperative pain after surgery under spinal anaesthesia. Journal of Anaesthesiology Clinical Pharmacology. 2014;30(3):373-77.
29. Serpell MG. Gabapentin in neuropathic pain syndromes: a randomised, doubleblind, placebo-controlled trial. Pain. 2002;99:557-66.
30. Maneuf YP, Gonzalez MI, Sutton KS, Chung FZ, Pinnock RD, Lee K. Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol Life Sci. 2003;60:742-50.
31. Tiippana E, Hamunen K, Kontinen VK, Kalso E. Do Surgical patients Benefit from Perioperative Gabapentin/Pregabalin? A Systematic Review of Efficacy and Safety. Anaesth Analg. 2007;104:1545–56.
32. Reuben SS, Ekman E. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am. 2005;87:536–42.
33. Reuben SS, Ekman EF, Raghunathan K, et al. The effect of cyclooxygenase-2 inhibition on acute and chronic pain after spinal-fusion surgery. Reg Anaesth Pain Med. 2006;31:6–13.
34. Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors in postoperative pain management. Current evidence and future directions. Anaesthesiology. 2003;99:1198–208.
35. Marret E, Kurdi O, Zufferey P, Bonnet F. Effect of nonsteroidal anti-inflammatory drugs on patient-controlled analgesia morphine side effects. Anaesthesiology. 2005;102: 1249–60.
36. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352:1081–91.
37. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352:1071–80.
38. Back M, Yin L, Ingelsson E. Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib. European Heart Journal. 2012;33:1928–33.
39. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332:1302–08.
40. Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, et al. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes. 2009;2:155–63.
41. Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005;365:475–81.